📰 Cosmetics Act News
Page 2 - Cosmetics Act News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Cosmetics Act. Real-time updates on events, politics, business and more.
May 22, 2024
A Massachusetts-based company will plead guilty to resolve allegations that it knowingly concealed a flaw in its lead blood tests that caused numerous inaccurate results.
May 22, 2024
BOSTON — A Massachusetts company will pay $42 million to settle claims that it concealed a medical device malfunction that produced inaccurately low lead test results for tens of thousands
May 20, 2024
The Delhi High Court has dismissed a Public Interest Litigation (PIL) seeking direction from the Centre to mandate all medical professionals practicing in the country to specify to a patient (in the form of an additional slip in the regional language) along with the prescription all kinds of possible risks and side effects associated with a drug or a pharmaceutical product being prescribed.
May 20, 2024
High Court said that the legislature has decided to impose this duty on drug manufacturers and pharmacists and the Court will not enter into judicial legislation.
May 20, 2024
The Delhi High Court has dismissed a public interest litigation (PIL) seeking a direction to all medical professionals to provide an additional slip detailing possible risks and side effects associated with prescribed medicines.A Bench, headed ...
May 20, 2024
New Delhi, May 20 (IANS) The Delhi High Court has dismissed a public interest litigation (PIL) seeking a direction to all medical professionals to pr
May 20, 2024
Get latest articles and stories on India at LatestLY. The Delhi High Court has dismissed a petition seeking that medical professionals be mandated to specify to a patient all kinds of possible risks and side effects associated with a drug being prescribed. India News | Delhi HC Dismisses Plea to Mandate Doctors Specify Drugs' Side Effects to Patient.
May 20, 2024
"Since the legislature in its wisdom has elected to impose this duty on the manufacturer and the pharmacist (to state about side effects), we do not find any ground for issuing a direction as prayed for in this PIL as it would amount to judicial legislation," the HC said in its May 15 order.
May 18, 2024
Ramdev News: An interim stay has been placed on the implementation of an order suspending manufacturing licenses for over a dozen medicines produced by Patanjali Ayurved Ltd and Divya Pharmacy. The stay follows a preliminary inquiry report from a high-level committee, stating that the suspension order was illegal and should not have been issued in the manner it was. The firms challenged the suspension order issued last month by the Uttarakhand state licensing authority, citing a lack of adherenc...
May 18, 2024
The World Bank has shared a set of 1,370 questions which will be assessed across various economies.